Moffitt at SITC
Moffitt Cancer Center’s research focuses on cutting-edge discoveries that can be rapidly translated into improved diagnostic, preventive and therapeutic advances. As pioneers of immunotherapy as a groundbreaking cancer treatment, we were excited to participate in the Society for Immunotherapy of Cancer Annual Meeting from November 8-12. The studies our scientists presented explored many advances in areas like radiomics, checkpoint inhibitors and TIL therapy covering many cancer types.
To learn more about Moffitt's research and breakthroughs, follow Moffitt on Twitter (@MoffittNews) and LinkedIn or subscribe to our newsletters.
2022 Featured Articles
Cellular Therapy May Be Viable Option for Advanced Melanoma Patients
Nearly one-third of patients respond to a single infusion of tumor infiltrating lymphocytes.
Using AI to Dictate Treatment for Non-Small Cell Lung Cancer
Data presented at the Society for Immunotherapy of Cancer shows AI can perform biomarker tests.
New Immunotherapy Could Be on the Horizon for Ovarian Cancer
Understanding tertiary lymphoid structures could unlock new treatments for a variety of cancers.
Phase 2 Bladder Cancer Trial Shows Promising Results
Updated data were presented at the 2022 SITC Annual Meeting.
Media Contact:
For additional information on Moffitt’s research presented at SITC please reach out to:
Kim Polacek, APR, CPRC
Senior PR Account Coordinator
Email
Videos
Moffitt Resources
Office of Innovation and Industry Alliances
Forging partnerships with startups and industry to bring cutting edge ideas and discovers to the marketplace.
Science & Research Careers
Our researchers drive cutting-edge discoveries that are rapidly translated into improved diagnostic, preventive and therapeutic advances.
Diversity, Equity and Inclusion
The diversity of our employees and communities is valued and supported as essential components to contributing to the prevention and cure of cancer.
Clinical Trials
With our robust portfolio of clinical trials, Moffitt remains firmly established at the forefront of cancer research.
Cell Therapies Core
The Cell Therapies Core provides service to members to facilitate translation of promising therapies for cancer patients.
Physician Liaison Team
Our goal is to forge partnerships with healthcare professionals to improve patient access and outcomes.
